Table 1.
Serological responses of the patient and his family members to MelV
| Person (age) | First bleed (April 3) | Second bleed (May 12) | Third bleed (June 9) |
|---|---|---|---|
| Immunofluorescence antibody tests titer IgM/IgG | |||
| MRA (39) | 1:80/1:640 | 1:40/1:2,560 | 1:10/1:2,560 |
| Wife (36) | NA | NA | 1:20/1:2,560 |
| Son (12) | NA | NA | −ve/−ve |
| Daughter (11) | NA | NA | 1:10/1:320 |
| Son (8) | NA | NA | −ve/−ve |
| Son (6) | NA | NA | 1:10/1:80 |
| Son (2) | NA | NA | −ve/−ve |
| Virus neutralization test titer | |||
| MRA (39) | 1:80 | 1:320 | 1:160 |
| Wife (36) | NA | NA | 1:40 |
| Son (12) | NA | NA | −ve |
| Daughter (11) | NA | NA | 1:160 |
| Son (8) | NA | NA | −ve |
| Son (6) | NA | NA | 1:40 |
| Son (2) | NA | NA | −ve |
NA, sera not available for testing; −ve, negative.